Latest news with #KayanSiodia
Fashion Value Chain
27-05-2025
- Health
- Fashion Value Chain
S.L. Raheja Hospital, Mumbai Completes 50 TAVI Procedures, Showcasing Excellence Minimally Invasive Heart Solutions
This milestone marks a major leap in delivering safer, faster, and more effective heart valve treatment for elderly and high-risk patients, setting high benchmarks for the hospitals Structural Heart Program In addition to its excellence in Cardiology, S.L. Raheja Hospital-a quaternary care center in Mumbai-offers advanced care in Oncology, Neurology, Orthopedics, Critical Care, Diabetology, and other specialties, ensuring comprehensive, patient-centered treatment Clinicians at the Department of Interventional Cardiology and Structural Heart Intervention at S.L. Raheja Hospital, Mahim – A Fortis Associate have successfully performed 50 Transcatheter Aortic Valve Implantation (TAVI) procedures – marking a significant milestone for cardiac care in the Mumbai region. This milestone puts S.L. Raheja Hospital, Mahim, at the forefront of cardiac care in Mumbai, with one of Mumbai's most advanced Structural Heart Programs. The milestone was achieved under the leadership of Dr. Haresh Mehta, Director – Interventional Cardiology and Structural Heart Interventions, along with Consultant – Interventional Cardiologists Dr. Kayan Siodia and Dr. Raghav Nagpal. (L-R) Dr Raghav Nagpal, Dr Haresh Mehta & Dr Kayan Siodia, Interventional Cardiology & Structural Heart Team at S.L. Raheja Hospital, Mumbai – A Fortis Associate TAVI is a minimally invasive procedure used to replace a narrowed Aortic Valve that fails to open properly, a condition known as Aortic Stenosis. It can be potentially life-changing for elderly and high-risk patients who are not suitable for open-heart surgery. Among the 50 procedures performed, the team has successfully navigated many complex cases – including bicuspid aortic valves (typically more challenging due to having two cusps instead of three) and extremely narrow femoral arteries, sometimes as small as 4.95 mm. In rare cases where femoral access was not feasible, the team has also performed trans carotid (neck-access) TAVIs with excellent results – demonstrating both technical expertise and adherence to standardized global best practices. Talking about the benefits of TAVI, Dr. Haresh Mehta, Director – Interventional Cardiology and Structural Heart Interventions, S.L. Raheja Hospital, Mahim – A Fortis Associate, said, 'Severe symptomatic Aortic Stenosis can limit a patient's life expectancy to just 2-to-5 years. Thus, TAVI, the procedure used to treat this condition, can bring about life-altering changes as it extends life, and also dramatically improves quality of life. Since it is minimally invasive, patients often feel relief within 24 hours of the procedure and are discharged within 48 hours – all without the need for open surgery, sutures, or any long recovery times. While TAVI is a key cardiac procedure, patients also benefit from a range of advanced treatments for other heart conditions, including pacemaker implantation, structural heart interventions, and coronary angioplasties.' Talking about the milestone, Dr. Kunal Punamiya, CEO, S.L. Raheja Hospital, Mahim – A Fortis Associate, said, 'This momentous achievement reflects our ongoing commitment to delivering cutting-edge cardiac interventions to those who need it the most. With this milestone, we continue to deliver world-class minimally invasive cardiac care that ensures improved outcomes, faster recovery, and enhanced quality of life. Our Structural Heart Program has been designed to provide cutting-edge cardiac therapies under one roof, which includes stenting and Angioplasty, Atherectomy, ICD and Pacemaker implantation, valve repair, and more. Additionally, we are equipped with a state-of-the-art Cath lab to support these advanced procedures.' This clinical achievement, like many others at S.L. Raheja Hospital Mumbai, reflect the hospital's unwavering commitment to compassionate care. It's milestones like these that allow the teams to keep pushing boundaries and touching lives – one patient at a time. About Fortis Healthcare Limited Fortis Healthcare Limited – an IHH Healthcare Berhad Company – is a leading integrated healthcare services provider in India. It is one of the largest healthcare organizations in the country with 27 healthcare facilities, ~4,750 operational beds (including O&M facilities), and over 400 diagnostics centers (including JVs). The Company is listed on the BSE Ltd and National Stock Exchange (NSE) of India. It draws strength from its partnership with a global major and parent company – IHH, to build upon its culture of world-class patient care and superlative clinical excellence. Fortis employs over 23,000 people (including Agilus Diagnostics Limited) who share its vision of becoming the world's most trusted healthcare network. Fortis offers a full spectrum of integrated healthcare services ranging from clinics to quaternary care facilities and a wide range of ancillary services.
Time of India
13-05-2025
- Health
- Time of India
S.L. Raheja Hospital completes 50 TAVI procedures in Mumbai
Mumbai: The Department of Interventional Cardiology and Structural Heart Intervention at S.L. Raheja Hospital , Mahim – A Fortis Associate, has completed 50 Transcatheter Aortic Valve Implantation (TAVI) procedures. According to the company, this comes under the leadership of Dr. Haresh Mehta , Director of Interventional Cardiology and Structural Heart Interventions, along with Dr. Kayan Siodia and Dr. Raghav Nagpal. TAVI is a minimally invasive procedure used to treat aortic stenosis, a condition where the heart's aortic valve becomes narrowed. It is often recommended for elderly or high-risk patients who are not eligible for open-heart surgery. According to the hospital, the team successfully managed several complex cases, including patients with bicuspid aortic valves and extremely narrow femoral arteries, some as small as 4.95 mm. In cases where femoral access was not possible, the team performed transcarotid (neck-access) procedures. The hospital states that outcomes have been consistent with global standards. Dr. Haresh Mehta, Director – Interventional Cardiology and Structural Heart Interventions, S.L. Raheja Hospital, Mahim - A Fortis Associate, said, 'Severe symptomatic Aortic Stenosis can limit a patient's life expectancy to just 2-to-5 years. Thus, TAVI, the procedure used to treat this condition, can bring about life-altering changes as it extends life and also dramatically improves quality of life. Since it is minimally invasive, patients often feel relief within 24 hours of the procedure and are discharged within 48 hours — all without the need for open surgery, sutures, or any long recovery times'.
News18
04-05-2025
- Health
- News18
The Role of Salt Reduction in Hypertension Management: New Evidence and Global Initiatives
Last Updated: Recent epidemiological data reaffirms that excessive sodium intake is inextricably linked to dysfunction of the vascular system, which in turn leads to cardiac issues, hypertension Salt—an ubiquitous ornament that graces tables across continents—has in recent times emerged as a central villain in the narrative of hypertension. In human physiology, salt plays a crucial role in maintaining the body's mineral content; however, the perils of excess have recently come to light. There is enough data—a burgeoning body of evidence—that addresses the benefits of curbing salt intake in hypertensive individuals. It is termed a silent predator that transforms healthy individuals into hypertensive patients. Even the young are not excluded from its effects. In fact, processed and stored foods, which are notorious for their high sodium chloride content, are largely consumed by the younger population. Dr. Kayan Siodia, Consultant Cardiologist, P. D. Hinduja Hospital & Medical Research Centre, Khar, Mumbai, shares evidence about the role of salt reduction in hypertension management. Recent epidemiological data reaffirms what many experts have long postulated: excessive sodium intake is inextricably linked to dysfunction of the vascular system, which in turn leads to cardiac issues and hypertension. Diets that have been widely studied and accepted—particularly the DASH (Dietary Approaches to Stop Hypertension) diet—demonstrate that even modest reductions in daily salt consumption can significantly lower both systolic and diastolic blood pressure. These findings offer true relief for the hypertensive population, grounded in data and time-tested results. Multifaceted campaigns have been launched in response to the growing hypertension crisis. Ambitious—yet achievable—targets have been set by the World Health Organization (WHO) to reduce global salt intake by 30% by 2027. Many countries, including India, have risen to the challenge with renewed fervour and enthusiasm. Clear salt labelling and mandatory nutritional disclosures on packaged foods are now enforced in India, empowering consumers to make informed choices. A wave of culinary reimagining is steering us toward a salt-conscious era. The omnipresence of salt in food remains a formidable hurdle. This journey is not without its impediments. However, the path forward is clear. Reducing even a small quantity of salt is a meaningful starting point for individuals with hypertension. It should be noted that salt reduction is not a substitute for prescribed medications, but rather a valuable adjunct in achieving better blood pressure control. First Published: May 04, 2025, 11:03 IST
